CorMedix Inc (CRMD NASDAQ) stock market data APIs
$11.0792
0.2(1.8%)
as of January 7, 2026
Try our APIs with
free plan!
CorMedix Inc Financial Data Overview
Price chart is built with
Anychart
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Prev. Close
11.0792
Open
11.2797
High
11.6459
Low
10.8511
52 wk Range
5.6-17.43
Market Cap
880 M
P/E Ratio
5.0543
Shares Outstanding
78 789 K
Revenue
214 M
EPS
1.406
Beta
1.361
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with CorMedix Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CorMedix Inc data using free add-ons & libraries
Get CorMedix Inc Fundamental Data
CorMedix Inc Fundamental data includes:
- Net Revenue: 214 M
- EBITDA: 108 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-28
- EPS/Forecast: 0.2233
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CorMedix Inc News
New
CNC Deepens Medicaid Strategy With Cityblock Partnership in Illinois
Centene Corporation CNC continues to sharpen its Medicaid-focused growth strategy with a new partnership between its Illinois subsidiary, Meridian Health Plan of Illinois, and Cityblock Health. The co...
CorMedix shares fall as 2026 revenue outlook disappoints (update)
* CorMedix Therapeutics (CRMD [https://seekingalpha.com/symbol/CRMD]) shares slipped [https://seekingalpha.com/pr/20357723-cormedix-therapeutics-announces-preliminary-fourth-quarter-and-full-year-20...
KRYS Stock Surges 57% in a Year: More Upside Potential in 2026?
Shares of Krystal Biotech KRYS have surged 57.2% in a year compared with the industry’s growth of 17.1%. The stock has also outperformed the industry and the sector in this time frame. The strong r...
EXEL Collaborates With Natera for Late-Stage Colorectal Cancer Study
Exelixis, Inc. EXEL announced that it has collaborated with Natera NTRA for the STELLAR-316 study. This phase III study is being sponsored by Exelixis. The study will evaluate Exelixis’ novel oral...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
